Nicolas Magné

10.0k total citations · 1 hit paper
318 papers, 6.1k citations indexed

About

Nicolas Magné is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nicolas Magné has authored 318 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Oncology, 111 papers in Pulmonary and Respiratory Medicine and 74 papers in Surgery. Recurrent topics in Nicolas Magné's work include Head and Neck Cancer Studies (30 papers), Advanced Radiotherapy Techniques (29 papers) and Endometrial and Cervical Cancer Treatments (29 papers). Nicolas Magné is often cited by papers focused on Head and Neck Cancer Studies (30 papers), Advanced Radiotherapy Techniques (29 papers) and Endometrial and Cervical Cancer Treatments (29 papers). Nicolas Magné collaborates with scholars based in France, Belgium and Colombia. Nicolas Magné's co-authors include Cyrus Chargari, Alexis Vallard, Jean‐Baptiste Guy, Claire Rodriguez‐Lafrasse, G. Milano, Christine Haie-Méder, C. Rancoule, Patricia Formento, Gersende Alphonse and Pierre Castadot and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Nicolas Magné

300 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial

2023 77 citations Nicolas Magné et al. profile →

Peers

Countries citing papers authored by Nicolas Magné

Since Specialization

Citations

This map shows the geographic impact of Nicolas Magné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Magné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Magné more than expected).

Fields of papers citing papers by Nicolas Magné

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Magné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Magné. The network helps show where Nicolas Magné may publish in the future.

Co-authorship network of co-authors of Nicolas Magné

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Magné. A scholar is included among the top collaborators of Nicolas Magné based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Magné. Nicolas Magné is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment 2024 ·Radiotherapy and Oncology ·Éric François, Nicolas Magné, Rabia Boulahssass, Philippe Ronchin, (unknown), (unknown), (unknown), C. Cattenoz, Isabelle Martel‐Lafay, C. Terret, Pascal Artru, P. Clavère, Achille Tchalla, V. Vendrely, (unknown), Valérie Boige, (unknown), Jocelyn Gal, Berardino De Bari	0
2	Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density 2023 ·Clinical and Translational Radiation Oncology ·(unknown), (unknown), Frédéric Guyon, (unknown), Coriolan Lebreton, (unknown), (unknown), (unknown), Wafa Bouleftour, Nicolas Magné, (unknown)	4
3	Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients 2022 ·Cancers ·Vincent Vinh‐Hung, (unknown), Nele Adriaenssens, Hilde Van Parijs, Guy Storme, Dirk Verellen, Nam P. Nguyen, Nicolas Magné, Mark De Ridder	1
4	Toxicity and efficacy of stereotactic body radiotherapy for ultra-central lung tumours: a single institution real life experience 2021 ·British Journal of Radiology ·Élodie Guillaume, Ronan Tanguy, (unknown), L. Claude, (unknown), Coralie Moncharmont, Nicolas Magné, Isabelle Martel‐Lafay	10
5	Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub‐analysis of the ProfiLER protocol 2021 ·Head & Neck ·(unknown), Nicolas Magné, Jérôme Fayette, Élisabeth Daguenet, S. Racadot, P. Pommier, Benoîte Méry, Alexis Vallard, Fabien Tinquaut, Eve‐Marie Neidhardt‐Berard, Philippe A. Cassier, Valéry Attignon, Daniel Pissaloux, Qing Wang, Emilie Sohier, David Pérol, Jean‐Yves Blay, Olivier Trédan	2
6	Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status 2020 ·Journal for ImmunoTherapy of Cancer ·(unknown), Georgia Karpathiou, Jean Marc Dumollard, Nicolas Magné, Jean Perrot, François Vassal, (unknown), Mousa Mobarki, Fabien Forest, François Casteillo, (unknown), Μarios E. Froudarakis, Michel Péoc’h	28
7	Persistent High‐Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer 2020 ·Case Reports in Obstetrics and Gynecology ·(unknown), Alfredo Romero-Rojas, (unknown), (unknown), (unknown), (unknown), (unknown), Mónica Molano, Óscar Gamboa, (unknown), (unknown), Alexis Vallard, Nicolas Magné	9
8	Prognostic significance of tumor budding, tumor‐stroma ratio, cell nests size, and stroma type in laryngeal and pharyngeal squamous cell carcinomas 2019 ·Head & Neck ·Georgia Karpathiou, (unknown), M. Gavid, (unknown), Jean Marc Dumollard, Nicolas Magné, Μarios E. Froudarakis, J.‐M. Prades, Michel Péoc’h	52
9	ROS Production and Distribution: A New Paradigm to Explain the Differential Effects of X-ray and Carbon Ion Irradiation on Cancer Stem Cell Migration and Invasion 2019 ·Cancers ·Anne‐Sophie Wozny, Guillaume Varès, Gersende Alphonse, (unknown), C. Monini, Nicolas Magné, Charlotte Cuerq, Akira Fujimori, Jean‐Claude Monboisse, Michaël Beuve, Tetsuo Nakajima, Claire Rodriguez‐Lafrasse	39
10	Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review 2018 ·Critical Reviews in Oncology/Hematology ·Romain Rivoirard, Julien Langrand-Escure, Mathieu Oriol, Fabien Tinquaut, Franck Chauvin, C. Rancoule, Nicolas Magné, Aurélie Bourmaud	1
11	Spinal meningioma and factors predictive of post-operative deterioration 2018 ·Journal of Neuro-Oncology ·Vianney Gilard, (unknown), (unknown), Florent Marguet, Nicolas Magné, (unknown), (unknown), Stéphane Derrey	30
12	Méthodologie des essais de phase I en radiothérapie : particularités 2016 ·Cancer/Radiothérapie ·Romain Rivoirard, Alexis Vallard, Julien Langrand-Escure, (unknown), (unknown), (unknown), (unknown), Benoîte Méry, (unknown), C. Rancoule, Nicolas Magné	1
13	Correlation of Physical Activities and Breast Cancer Characteristics: A Prospective Analysis with Special Focus on Triple Negative Breast Cancer 2015 ·Oncology ·Alexis Vallard, Alexander T. Falk, (unknown), Jean‐Baptiste Guy, Jean-Baptiste Guichard, Sophie Espenel, Julien Langrand-Escure, Jane‐Chloé Trone, Benoîte Méry, (unknown), (unknown), Guoping Wang, Frédéric Roche, (unknown), Cyrus Chargari, Aurélie Bourmaud, Nicolas Magné	3
14	A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN 2013 ·Annals of Oncology ·Bohuslav Melichar, Sergio Bracarda, В. Б. Матвеев, B. Yа. Alekseev, С. А. Иванов, A. V. Zyryаnov, Rasa Jančiauskienė, Eva Fernebro, Peter F.A. Mulders, Stuart Osborne, Sangeeta Jethwa, G. Mickisch, Martin Gore, R. Jeroen A. van Moorselaar, Michael Staehler, Nicolas Magné, Joaquim Bellmunt	24
15	Sarcoma of vulva, vagina and ovary 2011 ·Best Practice & Research Clinical Obstetrics & Gynaecology ·Nicolas Magné, (unknown), Pierre Auberdiac, Jean-Philippe Jacquin, Cyrus Chargari, Céline Chauleur, Christine Meder, Yacine Merrouche	21
16	Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer 2005 ·Oral Oncology ·Xavier Pivot, Nicolas Magné, Emmanuel Guardiola, G. Poissonnet, O. Dassonville, M Francoual, Jean–Louis Formento, René‐Jean Bensadoun, F Démard, M. Schneider, G. Milano	39
17	[Targeted therapies: last focus on EGF receptor inhibitors in breast cancer]. 2004 ·PubMed ·Nicolas Magné, G. Milano	2
18	Tolérance cardiaque des associations paclitaxel-anthracyclines dans le cadre de la prise en charge du cancer du sein 2003 ·Bulletin du Cancer ·Jean-Marc Ferrero, Nicolas Magné, Cyril Foa, Rémy Largillier, Moïse Namer	3
19	Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil 2003 ·British Journal of Cancer ·Nicolas Magné, J-L Fischel, Céline Tiffon, Patricia Formento, A Dubreuil, N. Renée, J. L. Formento, M Francoual, Joseph Ciccolini, (unknown), G. Milano	66
20	Séminome du testicule et ostéonécrose aseptique multifocale au décours d’une chimiothérapie 2001 ·La Revue de Médecine Interne ·Nicolas Magné, Cyril Foa, Jean-Noël Bruneton, Pierre‐Yves Marcy	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact